Rhumbline Advisers Neuro Pace Inc Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Neuro Pace Inc stock. As of the latest transaction made, Rhumbline Advisers holds 36,956 shares of NPCE stock, worth $337,408. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,956
Previous 17,227
114.52%
Holding current value
$337,408
Previous $211,000
94.79%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NPCE
# of Institutions
108Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$23.9 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$23.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.31MShares$21.1 Million2.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$12.6 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$12.5 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $227M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...